Biomarkers and surrogate endpoints in glaucoma clinical trials
Author:
Publisher
BMJ
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference48 articles.
1. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies;Lesko;Annu Rev Pharmacol Toxicol,2001
2. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers Definitions Working G;Clin Pharmacol Ther,2001
3. Surrogate endpoints: a basis for a rational approach;Boissel;Eur J Clin Pharmacol,1992
4. Surrogate endpoints in clinical trials: definition and operational criteria;Prentice;Stat Med,1989
5. Biomarkers in clinical drug development;Gobburu;Clin Pharmacol Ther,2009
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rates of visual field change and functional progression in glaucoma following trabecular microbypass implantation of iStent technologies: a meta-analysis;BMJ Open Ophthalmology;2024-02
2. Tablet‐based tests of everyday visual function in a diabetic macular oedema (DME) clinic waiting area: A feasibility study;Ophthalmic and Physiological Optics;2023-12-22
3. Outcome measures in childhood glaucoma: a systematic review of randomized controlled trials;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-04-29
4. Nanotechnology for surgical glaucoma treatment;Nanotechnology in Ophthalmology;2023
5. Patient-reported outcome measures should not be the primary outcome in glaucoma clinical trials of disease modification;British Journal of Ophthalmology;2022-07-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3